Methods for the treatment of seborrheic dermatitis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424702, 514562, 514864, A61K 31355

Patent

active

052908097

ABSTRACT:
A pharmaceutical product to be used as an adjuvant treatment of seborrheic dermatitis even in HIV positive subjects is disclosed. The pharmaceutical product makes use of methionine, vitamin E and selenium as active principles which directly or indirectly provide a protective response to the damage caused by lipoperoxidation. The pharmaceutical product, in combination with a diet rich in PUFA-PL (polyunsaturated fatty acids of phospholipids), causes skin homeostasis to be restored and the symptoms of skin dermatitis to regress.

REFERENCES:
patent: 4613622 (1986-09-01), Moeller et al.
Brenner, S. and Horwitz, C., "Possible Nutrient Mediators in Psoriasis and Seborrheic Dermatitis", Wld Rev. Nutr. Diet., vol. 55, pp. 165-182, 1988.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for the treatment of seborrheic dermatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for the treatment of seborrheic dermatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of seborrheic dermatitis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-577519

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.